T1	PROC 47 62	estudio clínico
#1	AnnotatorNotes T1	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T2	PROC 89 100	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	CHEM 105 116	amivantamab
T4	CHEM 119 129	lazertinib
T5	CHEM 134 145	bevacizumab
#3	AnnotatorNotes T5	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	LIVB 150 158	personas
#4	AnnotatorNotes T6	C0027361; Persons; Population Group
T7	PROC 159 173	diagnosticadas
#5	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	DISO 178 217	cáncer de pulmón de células no pequeñas
#6	AnnotatorNotes T8	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T9	Neg_cue 206 208	no
T10	Negated 209 217	pequeñas
T11	DISO 219 224	CPCNP
#7	AnnotatorNotes T11	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T12	DISO 258 266	mutación
T13	ANAT 310 327	partes del cuerpo
T14	PROC 350 361	tratamiento
#8	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	CHEM 366 377	osimertinib
#9	AnnotatorNotes T15	C4058811; osimertinib; Organic Chemical · Pharmacologic Substance
T16	CHEM 380 390	lazertinib
T17	PROC 412 460	Estudio de fase II, con un grupo y multicéntrico
T18	CHEM 464 475	amivantamab
T19	CHEM 477 487	lazertinib
T20	CHEM 490 501	bevacizumab
#10	AnnotatorNotes T20	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T21	LIVB 505 514	pacientes
#11	AnnotatorNotes T21	C0030705; Patients; Patient or Disabled Group
T22	DISO 519 523	CPNM
#12	AnnotatorNotes T22	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T23	DISO 537 545	mutación
T24	PROC 579 582	TKI
T25	PROC 586 590	EGFR
T26	LIVB 641 650	Pacientes
#13	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	DISO 655 694	cáncer de pulmón de células no pequeñas
#14	AnnotatorNotes T27	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T28	Neg_cue 683 685	no
T29	Negated 686 694	pequeñas
T30	DISO 702 710	mutación
T31	CHEM 729 733	EGFR
#15	AnnotatorNotes T31	C1739039; EGFR protein, human; Amino Acid, Peptide, or Protein · Receptor
T32	ANAT 760 777	partes del cuerpo
T33	PROC 800 811	tratamiento
#16	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	CHEM 816 827	osimertinib
#17	AnnotatorNotes T34	C4058811; osimertinib; Organic Chemical · Pharmacologic Substance
T35	CHEM 830 840	lazertinib
T36	LIVB 866 875	Pacientes
#18	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	DISO 880 885	NSCLC
#19	AnnotatorNotes T37	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T38	DISO 899 907	mutación
T39	DISO 1005 1022	NSCLC no escamoso
T40	Neg_cue 1011 1013	no
T41	Negated 1014 1022	escamoso
T42	PROC 1034 1050	histológicamente
T43	Neg_cue 1068 1070	no
T44	PROC 1086 1105	tratamiento radical
#20	AnnotatorNotes T44	C0332316; Radical procedure; Therapeutic or Preventive Procedure
T45	Negated 1086 1105	tratamiento radical
T46	DISO 1169 1177	mutación
T47	CHEM 1196 1200	EGFR
#21	AnnotatorNotes T47	C1739039; EGFR protein, human; Amino Acid, Peptide, or Protein · Receptor
T48	LIVB 1211 1220	pacientes
#22	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	DISO 1225 1233	deleción
#23	AnnotatorNotes T49	C1442161; Gene Deletion Abnormality; Cell or Molecular Dysfunction
T50	DISO 1358 1385	Progresión de la enfermedad
#24	AnnotatorNotes T50	C0242656; Disease Progression; Pathologic Function
T51	PROC 1397 1413	radiológicamente
T52	PROC 1420 1431	tratamiento
#25	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	CHEM 1443 1454	osimertinib
#26	AnnotatorNotes T53	C4058811; osimertinib; Organic Chemical · Pharmacologic Substance
T54	CHEM 1457 1467	lazertinib
T55	PROC 1472 1483	tratamiento
#27	AnnotatorNotes T55	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T56	CHEM 1488 1499	osimertinib
#28	AnnotatorNotes T56	C4058811; osimertinib; Organic Chemical · Pharmacologic Substance
T57	CHEM 1502 1512	lazertinib
T58	PROC 1526 1538	interrumpido
T59	Duration 1539 1554	al menos 8 días
T60	PROC 1623 1634	tratamiento
#29	AnnotatorNotes T60	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T61	CHEM 1639 1650	osimertinib
#30	AnnotatorNotes T61	C4058811; osimertinib; Organic Chemical · Pharmacologic Substance
T62	CHEM 1653 1663	lazertinib
T63	Duration 1705 1713	≥6 meses
T64	PROC 1725 1736	tratamiento
#31	AnnotatorNotes T64	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T65	CHEM 1741 1752	osimertinib
#32	AnnotatorNotes T65	C4058811; osimertinib; Organic Chemical · Pharmacologic Substance
T66	CHEM 1755 1765	lazertinib
T67	DISO 1771 1789	Enfermedad medible
T68	Age 1834 1842	≥18 años
T69	LIVB 1872 1881	Pacientes
#33	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	DISO 1913 1952	carcinoma de pulmón de células pequeñas
#34	AnnotatorNotes T70	C0149925; Small cell carcinoma of lung; Neoplastic Process
T71	DISO 1954 1958	CPCP
#35	AnnotatorNotes T71	C0149925; Small cell carcinoma of lung; Neoplastic Process
T72	LIVB 1964 1973	Pacientes
#36	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	DISO 1978 2012	metástasis cerebrales sintomáticas
T74	LIVB 2018 2027	pacientes
#37	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T75	DISO 2032 2053	metástasis cerebrales
#38	AnnotatorNotes T75	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T76	DISO 2054 2067	asintomáticas
#39	AnnotatorNotes T76	C0231221; Asymptomatic (finding); Finding
T77	Negated 2054 2067	asintomáticas
T78	PROC 2082 2090	tratadas
T79	LIVB 2141 2150	pacientes
#40	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	PROC 2170 2182	radioterapia
#41	AnnotatorNotes T80	C0041626; Ultraviolet Therapy; Therapeutic or Preventive Procedure | C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T81	PROC 2196 2203	cirugía
#42	AnnotatorNotes T81	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T82	DISO 2208 2242	metástasis cerebrales sintomáticas
T83	DISO 2299 2312	asintomáticos
#43	AnnotatorNotes T83	C0231221; Asymptomatic (finding); Finding
T84	Negated 2299 2312	asintomáticos
T85	Duration 2321 2331	≥2 semanas
T86	Neg_cue 2396 2399	sin
T87	PROC 2400 2432	tratamiento con corticosteroides
T88	Negated 2400 2411	tratamiento
T89	Negated 2416 2432	corticosteroides
T90	PROC 2452 2463	tratamiento
#44	AnnotatorNotes T90	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T91	PROC 2468 2484	corticosteroides
T92	Dose 2488 2499	dosis bajas
T93	Dose 2502 2507	10 mg
T94	Frequency 2507 2511	/día
T95	CHEM 2515 2525	prednisona
#45	AnnotatorNotes T95	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T96	Duration 2549 2567	al menos 2 semanas
T97	LIVB 2596 2605	Pacientes
#46	AnnotatorNotes T97	C0030705; Patients; Patient or Disabled Group
T98	Date 2641 2648	pasados
T99	DISO 2654 2678	enfermedad leptomeníngea
T100	LIVB 2683 2692	Pacientes
#47	AnnotatorNotes T100	C0030705; Patients; Patient or Disabled Group
T101	DISO 2697 2728	compresión de la médula espinal
#48	AnnotatorNotes T101	C0037926; Compression of spinal cord; Disease or Syndrome
T102	Neg_cue 2729 2731	no
T103	PROC 2732 2739	tratada
T104	Negated 2732 2739	tratada
T105	LIVB 2745 2754	pacientes
#49	AnnotatorNotes T105	C0030705; Patients; Patient or Disabled Group
T106	PROC 2768 2776	tratados
T107	PROC 2797 2804	cirugía
#50	AnnotatorNotes T107	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T108	PROC 2807 2819	radioterapia
#51	AnnotatorNotes T108	C0041626; Ultraviolet Therapy; Therapeutic or Preventive Procedure | C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T109	PROC 2832 2850	estado neurológico
T110	Duration 2867 2877	≥2 semanas
T111	Neg_cue 2928 2930	no
T112	PROC 2940 2972	tratamiento con corticosteroides
T113	Negated 2940 2951	tratamiento
T114	Negated 2956 2972	corticosteroides
T115	PROC 2992 3024	tratamiento con corticosteroides
T116	Dose 3028 3046	dosis bajas ≤10 mg
T117	Frequency 3046 3050	/día
T118	CHEM 3054 3064	prednisona
#52	AnnotatorNotes T118	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T119	LIVB 3083 3092	Pacientes
#53	AnnotatorNotes T119	C0030705; Patients; Patient or Disabled Group
T120	DISO 3097 3113	eventos adversos
#54	AnnotatorNotes T120	C0877248; Adverse event; Pathologic Function
T121	Neg_cue 3114 3116	no
T122	Negated 3117 3126	resueltos
T123	DISO 3141 3149	alopecia
#55	AnnotatorNotes T123	C0002170; Alopecia; Disease or Syndrome | C0497378; hair loss/baldness; Pathologic Function
T124	PROC 3158 3179	terapia anticancerosa
T125	Neg_cue 3193 3195	no
T126	Negated 3205 3213	resuelto
T127	LIVB 3251 3260	Pacientes
#56	AnnotatorNotes T127	C0030705; Patients; Patient or Disabled Group
T128	PROC 3265 3297	prueba de antígeno de superficie
T129	PROC 3299 3304	HBsAg
#57	AnnotatorNotes T129	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T130	DISO 3320 3331	hepatitis B
#58	AnnotatorNotes T130	C0019163; Hepatitis B; Disease or Syndrome
T131	DISO 3333 3356	virus de la hepatitis B
T132	DISO 3358 3361	VHB
